Journal of Reproductive Medicine, ISSN 0024-7758, 02/2017, Volume 62, Issue 1, pp. 79 - 81
BACKGROUND: Pregnant women are susceptible to visual disturbances, particularly with hypertension. Vision generally recovers postpartum within hours to days. A...
Vasculopathy | Microembolization | Retinopathy
Vasculopathy | Microembolization | Retinopathy
Journal Article
JOURNAL OF REPRODUCTIVE MEDICINE, ISSN 0024-7758, 01/2017, Volume 62, Issue 1-2, pp. 79 - 81
BACKGROUND: Pregnant women are susceptible to visual disturbances, particularly with hypertension. Vision generally recovers postpartum within hours to days. A...
retinopathy | vasculopathy | microembolization | OBSTETRICS & GYNECOLOGY
retinopathy | vasculopathy | microembolization | OBSTETRICS & GYNECOLOGY
Journal Article
Aging, ISSN 1945-4589, 11/2018, Volume 10, Issue 11, pp. 3136 - 3147
Coronary microembolization (CME) substantially reduces the clinical benefits of myocardial reperfusion therapy. Autophagy and apoptosis participate in the...
Egr-1 | Coronary microembolization | Autophagy | Apoptosis | Myocardial injury
Egr-1 | Coronary microembolization | Autophagy | Apoptosis | Myocardial injury
Journal Article
Oncotarget, 2017, Volume 8, Issue 59, pp. 99347 - 99358
Journal Article
Journal of Vascular Surgery, ISSN 0741-5214, 2019
AbstractBackgroundMicroembolization after carotid artery stenting (CAS) and carotid endarterectomy (CEA) has been documented and may confer risk for...
Surgery
Surgery
Journal Article
Circulation, ISSN 0009-7322, 02/2011, Volume 123, Issue 6, pp. 594 - 604
Background-Inflammation plays a key role in the pathophysiology of myocardial ischemia/reperfusion (I/R) injury; however, the mechanism by which myocardial I/R...
cytokine | hypoxia | inflammation | heart | leukocyte | APOPTOSIS | CELLS | CARDIAC & CARDIOVASCULAR SYSTEMS | SPECK-LIKE PROTEIN | CONTRACTILE DYSFUNCTION | CORONARY MICROEMBOLIZATION | NALP3 INFLAMMASOME | ASC | INFARCTION | PERIPHERAL VASCULAR DISEASE | MICE | Potassium - metabolism | Inflammasomes - metabolism | Reactive Oxygen Species - metabolism | Humans | Mice, Inbred C57BL | Middle Aged | Caspase 1 - metabolism | Male | Myocardial Infarction - metabolism | Myocardial Reperfusion Injury - metabolism | Inflammation - metabolism | Animals | Myocardium - metabolism | Myocytes, Cardiac - metabolism | Interleukin-1beta - biosynthesis | Mice | Cytokines - biosynthesis | Fibroblasts - metabolism | Mediators | Physiological aspects | Myocardial ischemia | Development and progression | Inflammation | Research | Reperfusion injury
cytokine | hypoxia | inflammation | heart | leukocyte | APOPTOSIS | CELLS | CARDIAC & CARDIOVASCULAR SYSTEMS | SPECK-LIKE PROTEIN | CONTRACTILE DYSFUNCTION | CORONARY MICROEMBOLIZATION | NALP3 INFLAMMASOME | ASC | INFARCTION | PERIPHERAL VASCULAR DISEASE | MICE | Potassium - metabolism | Inflammasomes - metabolism | Reactive Oxygen Species - metabolism | Humans | Mice, Inbred C57BL | Middle Aged | Caspase 1 - metabolism | Male | Myocardial Infarction - metabolism | Myocardial Reperfusion Injury - metabolism | Inflammation - metabolism | Animals | Myocardium - metabolism | Myocytes, Cardiac - metabolism | Interleukin-1beta - biosynthesis | Mice | Cytokines - biosynthesis | Fibroblasts - metabolism | Mediators | Physiological aspects | Myocardial ischemia | Development and progression | Inflammation | Research | Reperfusion injury
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2012, Volume 59, Issue 15, pp. 1383 - 1389
Objectives: The objective of this study was to compare the cerebral embolic load of filter-protected versus proximal balloonprotected carotid artery stenting...
carotid artery stenting | diffusion-weighted magnetic resonance imaging | cerebral embolic protection | DIFFUSION-WEIGHTED MRI | CARDIAC & CARDIOVASCULAR SYSTEMS | EMBOLIC PROTECTION | ISCHEMIA | ENDARTERECTOMY | MICROEMBOLIZATION | STROKE | ANGIOPLASTY | HIGH-RISK | DEVICES | UPDATE | Prospective Studies | Follow-Up Studies | Humans | Male | Treatment Outcome | Intracranial Embolism - epidemiology | Carotid Stenosis - complications | Balloon Occlusion - methods | Incidence | Intraoperative Complications | Carotid Stenosis - diagnosis | Intraoperative Care - methods | Diffusion Magnetic Resonance Imaging | Aged, 80 and over | Female | Aged | Intracranial Embolism - prevention & control | Intracranial Embolism - etiology | Stents | Carotid Stenosis - surgery
carotid artery stenting | diffusion-weighted magnetic resonance imaging | cerebral embolic protection | DIFFUSION-WEIGHTED MRI | CARDIAC & CARDIOVASCULAR SYSTEMS | EMBOLIC PROTECTION | ISCHEMIA | ENDARTERECTOMY | MICROEMBOLIZATION | STROKE | ANGIOPLASTY | HIGH-RISK | DEVICES | UPDATE | Prospective Studies | Follow-Up Studies | Humans | Male | Treatment Outcome | Intracranial Embolism - epidemiology | Carotid Stenosis - complications | Balloon Occlusion - methods | Incidence | Intraoperative Complications | Carotid Stenosis - diagnosis | Intraoperative Care - methods | Diffusion Magnetic Resonance Imaging | Aged, 80 and over | Female | Aged | Intracranial Embolism - prevention & control | Intracranial Embolism - etiology | Stents | Carotid Stenosis - surgery
Journal Article
Circulation, ISSN 0009-7322, 03/2009, Volume 119, Issue 10, pp. 1386 - 1397
Background - Although preclinical data suggested that tumor necrosis factor-alpha (TNF) neutralization in heart failure (HF) would be beneficial, clinical...
Heart failure | Inflammation | Remodeling | Tumor necrosis factor | CARDIAC-FUNCTION | PATHWAYS | heart failure | remodeling | OXIDATIVE STRESS | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | CORONARY MICROEMBOLIZATION | FACTOR-ALPHA | MURINE MODEL | INHIBITION | tumor necrosis factor | LEFT-VENTRICULAR DYSFUNCTION | inflammation | PERIPHERAL VASCULAR DISEASE | TNF-ALPHA
Heart failure | Inflammation | Remodeling | Tumor necrosis factor | CARDIAC-FUNCTION | PATHWAYS | heart failure | remodeling | OXIDATIVE STRESS | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | CORONARY MICROEMBOLIZATION | FACTOR-ALPHA | MURINE MODEL | INHIBITION | tumor necrosis factor | LEFT-VENTRICULAR DYSFUNCTION | inflammation | PERIPHERAL VASCULAR DISEASE | TNF-ALPHA
Journal Article
NEUROSURGERY, ISSN 0148-396X, 01/2017, Volume 80, Issue 1, pp. 65 - 65
Journal Article
Circulation, ISSN 0009-7322, 11/2008, Volume 118, Issue 19, pp. 1915 - 1919
Signal transduction | Nitric oxide synthase | Editorials | Reperfusion | Ischemia | Nitric oxide | CARDIAC & CARDIOVASCULAR SYSTEMS | ATP CHANNELS | MYOCARDIAL-INFARCTION | LATE-PHASE | HIBERNATING MYOCARDIUM | NECROSIS-FACTOR-ALPHA | CORONARY MICROEMBOLIZATION | PERMEABILITY TRANSITION | ISCHEMIA-REPERFUSION INJURY | SENSITIVE K+ CHANNEL | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | MOUSE HEARTS | Protein Kinases - metabolism | Myocardial Stunning - metabolism | Animals | Ischemic Preconditioning, Myocardial | Humans | Mitochondria - metabolism | Nitric Oxide - metabolism | Prevention | Mitochondria | Physiological aspects | Research | Protein kinases | Heart attack
Journal Article
Experimental and Clinical Cardiology, ISSN 1205-6626, 2014, Volume 20, Issue 1, pp. 2246 - 2274
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 05/2018, Volume 499, Issue 2, pp. 267 - 272
The glucagon-like peptide-1 analog liraglutide has been proved to exert cardioprotective role via activating prosurvival pathways and suppressing inflammation....
Pyroptosis | NLRP3 inflammasome | SIRT1 | Liraglutide | H9c2 cells | APOPTOSIS | ACTIVATION | MYOCARDIAL-INFARCTION | BIOCHEMISTRY & MOLECULAR BIOLOGY | HEART-FAILURE | ACUTE LUNG INJURY | CORONARY MICROEMBOLIZATION | PROTECTS | BIOPHYSICS | DISEASE | MICE | OUTCOMES | Glucagon | Cardiology
Pyroptosis | NLRP3 inflammasome | SIRT1 | Liraglutide | H9c2 cells | APOPTOSIS | ACTIVATION | MYOCARDIAL-INFARCTION | BIOCHEMISTRY & MOLECULAR BIOLOGY | HEART-FAILURE | ACUTE LUNG INJURY | CORONARY MICROEMBOLIZATION | PROTECTS | BIOPHYSICS | DISEASE | MICE | OUTCOMES | Glucagon | Cardiology
Journal Article
FRONTIERS IN BIOSCIENCE-LANDMARK, ISSN 1093-9946, 01/2019, Volume 24, pp. 723 - 734
There is still no satisfactory large-animal model of ischemic heart failure (IHF) with ideal survival rate and model time. The aim of this study is to explore...
MYOCARDIUM | Chronic Heart Failure | LARGE ANIMAL-MODEL | Animal Model | BIOCHEMISTRY & MOLECULAR BIOLOGY | CARDIOMYOPATHY | SEQUENTIAL CORONARY MICROEMBOLIZATION | OVINE MODEL | Coronary Ligation | Miniature Pig | CELL BIOLOGY
MYOCARDIUM | Chronic Heart Failure | LARGE ANIMAL-MODEL | Animal Model | BIOCHEMISTRY & MOLECULAR BIOLOGY | CARDIOMYOPATHY | SEQUENTIAL CORONARY MICROEMBOLIZATION | OVINE MODEL | Coronary Ligation | Miniature Pig | CELL BIOLOGY
Journal Article
Pharmacology, ISSN 0031-7012, 06/2019, Volume 104, Issue 1-2, pp. 90 - 97
Background: Coronary microembolisation (CME)-induced myocardial apoptosis is a key factor in progressive cardiac dysfunction. Aloperine (ALO) plays a...
Research Article | Coronary microembolisation | Aloperine | Apoptosis | Myocardial injury | PI3K/Akt | CARDIOMYOCYTE APOPTOSIS | SIGNALING PATHWAY | SWINE | PHARMACOLOGY & PHARMACY | NICORANDIL | MICROEMBOLIZATION
Research Article | Coronary microembolisation | Aloperine | Apoptosis | Myocardial injury | PI3K/Akt | CARDIOMYOCYTE APOPTOSIS | SIGNALING PATHWAY | SWINE | PHARMACOLOGY & PHARMACY | NICORANDIL | MICROEMBOLIZATION
Journal Article
Journal of Molecular and Cellular Cardiology, ISSN 0022-2828, 2009, Volume 47, Issue 1, pp. 32 - 40
Abstract Lethal reperfusion injury is now recognized as a major limitation of current reperfusion therapy by primary percutaneous coronary intervention for...
Cardiovascular | Signal transducer and activator of transcription | Tumor necrosis factor alpha | Ischemia | Protective signaling pathways | Reperfusion injury | PERMEABILITY TRANSITION PORE | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-FAILURE | MYOCARDIAL ISCHEMIA/REPERFUSION INJURY | CARDIAC MYOCYTE | CORONARY MICROEMBOLIZATION | CELL BIOLOGY | TUMOR-NECROSIS-FACTOR | INDUCED CARDIOPROTECTION | TNF-ALPHA | ISCHEMIA-REPERFUSION | SIGNAL TRANSDUCER | Tumor Necrosis Factor-alpha - metabolism | Myocardial Reperfusion Injury - metabolism | Animals | Models, Biological | Humans | Tumor Necrosis Factor-alpha - physiology | Signal Transduction - physiology | STAT3 Transcription Factor - metabolism
Cardiovascular | Signal transducer and activator of transcription | Tumor necrosis factor alpha | Ischemia | Protective signaling pathways | Reperfusion injury | PERMEABILITY TRANSITION PORE | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-FAILURE | MYOCARDIAL ISCHEMIA/REPERFUSION INJURY | CARDIAC MYOCYTE | CORONARY MICROEMBOLIZATION | CELL BIOLOGY | TUMOR-NECROSIS-FACTOR | INDUCED CARDIOPROTECTION | TNF-ALPHA | ISCHEMIA-REPERFUSION | SIGNAL TRANSDUCER | Tumor Necrosis Factor-alpha - metabolism | Myocardial Reperfusion Injury - metabolism | Animals | Models, Biological | Humans | Tumor Necrosis Factor-alpha - physiology | Signal Transduction - physiology | STAT3 Transcription Factor - metabolism
Journal Article
Journal of Molecular and Cellular Cardiology, ISSN 0022-2828, 2011, Volume 52, Issue 4, pp. 890 - 896
Abstract The interventional implantation of a stent into an atherosclerotic coronary artery is a unique and paradigmatic scenario of plaque rupture in humans....
Cardiovascular | Coronary microembolization | Plaque rupture | TNFα | Serotonin | No reflow phenomenon | Thromboxane | Protection device | Coronary aspirate | MICROVASCULAR OBSTRUCTION | CARDIAC & CARDIOVASCULAR SYSTEMS | TNF alpha | PERCUTANEOUS INTERVENTION | NO-REFLOW PHENOMENON | EUROPEAN-SOCIETY | MICROEMBOLIZATION | CELL BIOLOGY | STENT IMPLANTATION | TASK-FORCE | THROMBUS ASPIRATION | ACUTE MYOCARDIAL-INFARCTION | DISTAL EMBOLIZATION | Coronary Vessels - pathology | Coronary Artery Disease - therapy | Coronary Artery Disease - physiopathology | Coronary Circulation - physiology | Humans | Coronary Artery Disease - pathology | Stents | Angioplasty, Balloon, Coronary
Cardiovascular | Coronary microembolization | Plaque rupture | TNFα | Serotonin | No reflow phenomenon | Thromboxane | Protection device | Coronary aspirate | MICROVASCULAR OBSTRUCTION | CARDIAC & CARDIOVASCULAR SYSTEMS | TNF alpha | PERCUTANEOUS INTERVENTION | NO-REFLOW PHENOMENON | EUROPEAN-SOCIETY | MICROEMBOLIZATION | CELL BIOLOGY | STENT IMPLANTATION | TASK-FORCE | THROMBUS ASPIRATION | ACUTE MYOCARDIAL-INFARCTION | DISTAL EMBOLIZATION | Coronary Vessels - pathology | Coronary Artery Disease - therapy | Coronary Artery Disease - physiopathology | Coronary Circulation - physiology | Humans | Coronary Artery Disease - pathology | Stents | Angioplasty, Balloon, Coronary
Journal Article
Basic Research in Cardiology, ISSN 0300-8428, 1/2012, Volume 107, Issue 1, pp. 1 - 17
Persistent inflammatory responses participate in the pathogenesis of adverse ventricular remodeling after myocardial infarction (MI). We hypothesized that...
Myocardial infarction | Cardiac remodeling | Medicine & Public Health | Cardiology | Regulatory T cells | CD28 superagonists | CARDIAC & CARDIOVASCULAR SYSTEMS | TROPONIN I-AUTOANTIBODIES | CONTRACTILE DYSFUNCTION | HEART-FAILURE | NECROSIS-FACTOR-ALPHA | CORONARY MICROEMBOLIZATION | ISCHEMIC CARDIOMYOPATHY | MICE | TNF-ALPHA | INFLAMMATORY RESPONSE | EXPRESSION | Interleukins | Genetic research | Inflammation | Universities and colleges | T cells | Macrophages | Heart attack
Myocardial infarction | Cardiac remodeling | Medicine & Public Health | Cardiology | Regulatory T cells | CD28 superagonists | CARDIAC & CARDIOVASCULAR SYSTEMS | TROPONIN I-AUTOANTIBODIES | CONTRACTILE DYSFUNCTION | HEART-FAILURE | NECROSIS-FACTOR-ALPHA | CORONARY MICROEMBOLIZATION | ISCHEMIC CARDIOMYOPATHY | MICE | TNF-ALPHA | INFLAMMATORY RESPONSE | EXPRESSION | Interleukins | Genetic research | Inflammation | Universities and colleges | T cells | Macrophages | Heart attack
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 07/2019, Volume 855, pp. 244 - 251
Coronary microembolization (CME) is responsible for a substantial fraction of microvascular obstruction (MVO), which are strongly associated with mortality and...
PTEN | Coronary microembolization | Cardiomyocyte | miR-486 | Apoptosis | MICROVASCULAR OBSTRUCTION | MYOCARDIAL-INFARCTION | SIGNALING PATHWAY | INJURY | NO-REFLOW PHENOMENON | CELL-SIZE | PHARMACOLOGY & PHARMACY | Transluminal angioplasty | Heart | Phosphatases | MicroRNA | Luciferase | Mortality | Genetic research | Cardiology | Health aspects
PTEN | Coronary microembolization | Cardiomyocyte | miR-486 | Apoptosis | MICROVASCULAR OBSTRUCTION | MYOCARDIAL-INFARCTION | SIGNALING PATHWAY | INJURY | NO-REFLOW PHENOMENON | CELL-SIZE | PHARMACOLOGY & PHARMACY | Transluminal angioplasty | Heart | Phosphatases | MicroRNA | Luciferase | Mortality | Genetic research | Cardiology | Health aspects
Journal Article
Circulation research, ISSN 0009-7330, 2008, Volume 102, Issue 2, pp. 257 - 264
Left ventricular (LV) remodeling leads to congestive heart failure and is a main determinant of morbidity and mortality following myocardial infarction....
Myocardial infarction | Remodeling | Toll-like receptor 4 | remodeling | CARDIAC & CARDIOVASCULAR SYSTEMS | CONTRACTILE DYSFUNCTION | myocardial infarction | HEART-FAILURE | CORONARY MICROEMBOLIZATION | TOLL-LIKE RECEPTOR-4 | FIBRONECTIN | PERIPHERAL VASCULAR DISEASE | TNF-ALPHA | TARGETED DELETION | HEMATOLOGY | MATRIX-METALLOPROTEINASE INHIBITION | EXPRESSION | 4-DEFICIENT MICE | Heart - physiopathology | Stroke Volume | Toll-Like Receptor 4 - physiology | Heart Failure - therapy | Ventricular Remodeling | Animals | Toll-Like Receptor 4 - deficiency | Gene Expression Regulation | Myocardial Infarction - physiopathology | Mice | Cytokines - genetics
Myocardial infarction | Remodeling | Toll-like receptor 4 | remodeling | CARDIAC & CARDIOVASCULAR SYSTEMS | CONTRACTILE DYSFUNCTION | myocardial infarction | HEART-FAILURE | CORONARY MICROEMBOLIZATION | TOLL-LIKE RECEPTOR-4 | FIBRONECTIN | PERIPHERAL VASCULAR DISEASE | TNF-ALPHA | TARGETED DELETION | HEMATOLOGY | MATRIX-METALLOPROTEINASE INHIBITION | EXPRESSION | 4-DEFICIENT MICE | Heart - physiopathology | Stroke Volume | Toll-Like Receptor 4 - physiology | Heart Failure - therapy | Ventricular Remodeling | Animals | Toll-Like Receptor 4 - deficiency | Gene Expression Regulation | Myocardial Infarction - physiopathology | Mice | Cytokines - genetics
Journal Article
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, ISSN 0363-6135, 06/2019, Volume 316, Issue 6, pp. H1439 - H1446
This opinionated article reviews current concepts of myocardial ischemia. Specifically, the historical background is briefly presented. Then, the prevailing...
MECHANICAL REPERFUSION | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | myocardial infarction | REGIONAL DYSFUNCTION | hibernation | stunning | EXERCISE | MICROEMBOLIZATION | INFARCT SIZE | HEART | RESERVE | BETA-BLOCKADE | PERIPHERAL VASCULAR DISEASE | myocardial ischemia | coronary blood flow | PERFUSION-PRESSURE | CARDIOPROTECTION | reperfusion
MECHANICAL REPERFUSION | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | myocardial infarction | REGIONAL DYSFUNCTION | hibernation | stunning | EXERCISE | MICROEMBOLIZATION | INFARCT SIZE | HEART | RESERVE | BETA-BLOCKADE | PERIPHERAL VASCULAR DISEASE | myocardial ischemia | coronary blood flow | PERFUSION-PRESSURE | CARDIOPROTECTION | reperfusion
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.